Abiopharma

🔍 MOORE HUBERT PHILLIP JR (Executive)

Company: NICOLET BANKSHARES INC (NIC)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Sold 65 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: G | equity_swap_involved: 0 | shares_owned_after: 38,991.00 | transaction_form_type: 4
• Acquired 65 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: G | equity_swap_involved: 0 | shares_owned_after: 65.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 65 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: G | equity_swap_involved: 0 | shares_owned_after: 38,926.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 65 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: G | equity_swap_involved: 0 | shares_owned_after: 65.00 | transaction_form_type: 4 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: H | nature_of_ownership: By Spouse's IRA | shares_owned_after: 400.00

Footnotes:

• F1: I disclaim beneficial ownership of these holdings by my adult son, I have no pecuniary interest in the holdings, and the filing of this report is not an admission that I am the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
• F2: Includes 41 shares acquired under the Employee Stock Purchase Plan, since my previous Form 4 filing dated February 17, 2026. I own a total of 503 shares in the Employee Stock Purchase Plan as of the date of this report.
• F3: I disclaim beneficial ownership of these holdings held by my adult son, I have no pecuniary interest in the holdings, and the filing of this report is not an admission that I am the beneficial owner of these shares for purposes of Section 16 or for any other purpose.